Delivery Order SPE2DB20D3111-SPE2DB24FA6FB

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,187.60 firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $1,187.60 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply pharmaceuticals and medical supplies to support the Department of Defense's...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract has a potential value of $1,641.60 and a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,781.40 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, in support of military treatment programs and facilities. The delivery order has a completion date of March 5, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,528.00 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a potential value of $2,764.86. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $1,187.60 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,268.25 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order contract has a performance period through February 14, 2024. Amerisourcebergen Drug Corp has previously been awarded an indefinite delivery contract (IDC) from DLA, which serves as the primary contract vehicle for the company...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract (SPE2DX15D3015|SPE2DX24F0GR0) by the Defense Logistics Agency (DLA) Troop Support Medical to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The award has a ceiling value of $2,495.23 and a period of performance through March 25, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, with a potential value of $5,605.20. The delivery order has a completion date of February 23, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31,...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA6FB
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,006.25 firm fixed price delivery order by the Defense Logistics Agency (DLA). The order is for Lantus SoloStar 100 unit/mL 3mL, a specialty pharmaceutical product. The delivery order has a completion date of January 12, 2024 and was awarded on January 11, 2024. This order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 4/26/24, 9:49 AM